Core Insights - Wellgistics Health has selected five blockchain platforms to develop its PharmacyChain™ smart contracts-enabled pharmaceutical drug tracking system, which aims to support industry-wide serialization mandates [1][2] - The U.S. prescription drugs market is projected to grow from $634 billion to $883 billion by 2030, while the global blockchain in healthcare market is expected to expand from $11 billion in 2024 to $214 billion by 2030 [1][2] - Wellgistics aims to complete the development of its PharmacyChain™ by the end of Q2 2026, initially operational within its own pharmacy [1] Company Overview - Wellgistics Health, Inc. is a leader in health information technology, integrating its AI platform EinsteinRx™ with its blockchain-enabled smart contracts platform PharmacyChain™ [1] - The company connects over 6,500 pharmacies and 200 manufacturers, providing a range of services including wholesale distribution and digital prescription routing [1] - Wellgistics holds exclusive intellectual property licensed from Datavault AI, creating a competitive advantage in the $4.9 trillion U.S. healthcare market [1] Market Opportunities - The global healthcare as a service market is expected to grow from $25 billion in 2024 to $74 billion by 2030, driven by the adoption of cloud-based solutions [1] - PwC estimates a $1 trillion opportunity to shift healthcare spending towards a digital-first, proactive, and personalized care system [1] - The integration of blockchain-based smart contracts and AI is anticipated to enhance transparency and efficiency in healthcare, improving patient outcomes [1]